CSI Market
Sign In | Register

Biotricity Inc (BTCY) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BTCY Annual Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Biotricity Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
9 Months 		(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Operating Activities
Income-8.42
Depreciation & amortization0.01
Amortization of Other Assets0.00
Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.32
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.78
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Change In Fair Value Of Derivative Liabilities-
Accretion Expense And Day One Derivative Loss-
Change In Fair Value Of Derivative Liabilities-
Fair Value Of Warrants Issued-
Issuance Of Shares For Services0.00
Issuance Of Warrants For Services At Fair Value0.04
Accretion Expense Including Day One Derivative Loss-
Change In Fair Value Of Derivative Liabilities-
Harmonized Sales Tax Recoverable Increase Decrease-
Derivative Gain Loss On Derivative Net0.17
Loss Gain On Debt Conversion And Redemption0.00
Right Of Use Assets Amortization0.34
Noncash Lease Expenses-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-0.86
Increase (Decrease) in Accounts Payable and Accrued Liabilities1.50
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities2.19
Discontinued operations0.00
Net Cash flow from Operating Activities-2.38
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net-1.73
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments1.84
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.13
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock1.73
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.03
Proceeds From Issuance Of Convertible Promissory Notes-
Due To Shareholders-
Issuance Of Shares-
Proceeds From Issuance Of Convertible Notes Net Of Issuance Costs-
Proceeds From Issuance Of Stock Options-
Issuance Of Shares-
Issuance Of Shares Net Of Cash Issuance Costs-
Issuance Of Shares Net-
Proceeds From Stock Options And Warrant Exercises-
Proceeds From Issuance Of Convertible Promissory Notes And Short Term Loans-
Proceeds From Federally Guaranteed Loans-
Dividend On Preferred Stock-
Proceeds From Issuance Of Shares From Uplisting-
Payments of Ordinary Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.93
Effect of exchange rate on cash flow0.03
Discontinued operations0.00
Free Cash Flow-2.38
Total Cash Flow-0.45
4 historic quarters locked

Sign in to unlock the full Biotricity Inc cash flow history.

Sign In Create Free Account

About Biotricity Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 19, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-039209

Figures are derived from filed reports and may be restated. Historical data is subject to revision.